Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”

Babjuk, 2017, EAU guidelines on nonmuscle-invasive urothelial carcinoma of the bladder: update 2016, Eur Urol, 71, 447, 10.1016/j.eururo.2016.05.041

Mostofi, 1973

Moch, 2016

Epstein, 1998, The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee, Am J Surg Pathol, 22, 1435, 10.1097/00000478-199812000-00001

Cheng, 2000, Flat intraepithelial lesions of the urinary bladder, Cancer, 88, 625, 10.1002/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.0.CO;2-A

Malmstrom, 1987, Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up, Scand J Urol Nephrol, 21, 185, 10.3109/00365598709180320

Pauwels, 1988, Grading in superficial bladder cancer. (1). Morphological criteria, Morphological criteria. Br J Urol, 61, 129, 10.1111/j.1464-410X.1988.tb05060.x

Eble, 2004

Barbisan, 2008, Immunohistochemical evaluation of global DNA methylation and histone acetylation in papillary urothelial neoplasm of low malignant potential, Int J Immunopathol Pharmacol, 21, 615, 10.1177/039463200802100315

Lee, 2014, Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder, Virchows Arch, 464, 213, 10.1007/s00428-013-1518-x

Pan, 2010, Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1515 cases, Am J Clin Pathol, 133, 788, 10.1309/AJCP12MRVVHTCKEJ

Samaratunga, 2002, Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression, Urology, 60, 315, 10.1016/S0090-4295(02)01705-3

Compérat, 2015, Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old, Virch Arch, 466, 589, 10.1007/s00428-015-1739-2

Pich, 2001, Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder, Am J Surg Pathol, 25, 1528, 10.1097/00000478-200112000-00009

Holmäng, 2002, Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression, J Urol, 167, 1634, 10.1016/S0022-5347(05)65168-3

McKenney, 2001, Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion, Am J Surg Pathol, 25, 356, 10.1097/00000478-200103000-00010

Hurle, 2016, Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project, BJU Int, 118, 935, 10.1111/bju.13536

Breyer, 2017, Increased proliferation as independent predictor of disease recurrence in initial stage pta urothelial bladder cancer, Bladder Cancer, 3, 173, 10.3233/BLC-170103

Heney, 1983, Superficial bladder cancer: progression and recurrence, J Urol, 130, 1083, 10.1016/S0022-5347(17)51695-X

Compérat, 2013, An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps, Histopathology, 63, 756, 10.1111/his.12214

Soukup, 2017, Eur Urol, 72, 801, 10.1016/j.eururo.2017.04.015

Cao, 2010, Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma, Urology, 76, 593, 10.1016/j.urology.2010.01.032

Yin, 2004, Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up, Am J Clin Pathol, 121, 679, 10.1309/0KATYHQBJD5XHQ8J

May, 2010, Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications, Eur Urol, 57, 850, 10.1016/j.eururo.2009.03.052

Lokeshwar, 2015, Impact of 2004 ISUP/WHO classification on bladder cancer grading, World J Urol, 33, 1929, 10.1007/s00345-015-1548-x

Otto, 2011, The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer, BJU Int, 107, 404, 10.1111/j.1464-410X.2010.09515.x

van Rhijn, 2010, The pathologist’s mean grade is constant and individualizes the prognostic value of bladder cancer grading, Eur Urol, 57, 1052, 10.1016/j.eururo.2009.09.022

Campbell, 2004, Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome, BJU Int, 93, 1228, 10.1111/j.1464-410X.2004.04848.x

Gonül, 2007, Comparisonof 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases, Urol Int, 78, 338, 10.1159/000100839

Pellucchi, 2011, Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors, J Urol, 186, 2194, 10.1016/j.juro.2011.07.070

Mai, 2013, Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance, Virchow Arch, 463, 575, 10.1007/s00428-013-1456-7

Reis, 2016, Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder, Human Pathol, 47, 20, 10.1016/j.humpath.2015.09.007

Cheng, 2000, Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma, Cancer, 88, 1663, 10.1002/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8

Gofrit, 2014, Mixed high and low grade bladder tumors—are they clinically high or low grade?, J Urol, 191, 1693, 10.1016/j.juro.2013.11.056

Downes, 2017, Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway, Histopathology, 70, 281, 10.1111/his.13063

Sjödahl, 2017, Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification, J Pathol, 242, 113, 10.1002/path.4886

Patschan, 2015, A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma, Eur Urol, 68, 824, 10.1016/j.eururo.2015.02.021

Yun, 2016, How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy, Investig Clin Urol, 57, S44, 10.4111/icu.2016.57.S1.S44

Compérat, 2007, Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms, Virchows Arch, 450, 419, 10.1007/s00428-007-0383-x

van Rhijn, 2010, Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer, Eur Urol, 58, 433, 10.1016/j.eururo.2010.05.043

van Oers, 2007, FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours, Eur Urol, 52, 760, 10.1016/j.eururo.2007.01.009

Burger, 2008, Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study, Eur Urol, 54, 835, 10.1016/j.eururo.2007.12.026

Murphy, 2002, Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care, J Urol, 168, 968, 10.1016/S0022-5347(05)64553-3

Bol, 2003, Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder, J Urol, 169, 1291, 10.1097/01.ju.0000055471.78783.ae

Dyrskjot, 2017, Prognostic impact of a 12-gene progression score in non-muscle-invasive bladder cancer: a prospective multicentre validation study, Eur Urol, 72, 461, 10.1016/j.eururo.2017.05.040

Meeks, 2016, Genomic characterization of high-risk non-muscle invasive bladder cancer, Oncotarget, 7, 75176, 10.18632/oncotarget.12661

Pietzak, 2017, Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets, Eur Urol, 72, 952, 10.1016/j.eururo.2017.05.032

Sjödahl, 2013, Toward a molecular pathologic classification of urothelial carcinoma, Am J Pathol, 183, 681, 10.1016/j.ajpath.2013.05.013

Choi, 2013, CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder, Int J Urol, 20, 251, 10.1111/j.1442-2042.2012.03128.x

Stern, 1979, Unusual benign bladder tumor of Brunn nest origin, Urology, 14, 288, 10.1016/0090-4295(79)90505-3

Lin, 2003, Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases, Mod Pathol, 16, 1289, 10.1097/01.MP.0000094091.04541.FC

Venyo, 2013, Microcystic variant of urothelial carcinoma, Adv Urol, 2013, 654751, 10.1155/2013/654751

Brimo, 2015, Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant, Hum Pathol, 46, 1506, 10.1016/j.humpath.2015.06.010

Cox, 2011, Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma, Am J Surg Pathol, 35, 1337, 10.1097/PAS.0b013e318222a653

Comperat, 2017, Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases, Histopathology, 71, 703, 10.1111/his.13280